Form D — Trace Biosciences Inc.
0002147501-26-000002 · filed Aug 12, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $16,234,498
- Reported amount sold
- $8,334,499
- Minimum investment
- $0
- Investors
- 19
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Trace Biosciences Inc.
- CIK
- 2147501
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 1800 NW 167TH PL
BEAVERTON, Oregon 97006 - Phone
- (971) 202-0545
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Connor Barth · Executive OfficerBeaverton, Oregon Find on LinkedIn ↗
-
Summer Gibbs · Executive OfficerBeaverton, Oregon Find on LinkedIn ↗
-
Lei Wang · Executive OfficerBeaverton, Oregon Find on LinkedIn ↗
-
Jonathan Sorger · DirectorBeaverton, Oregon Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗